Skip to main content
. 2022 May 26;5:660581. doi: 10.3389/frai.2022.660581

Figure 5.

Figure 5

Hazard ratios (with 95% confidence intervals) for the progression to AD for the two subgroups and all subjects when comparing the placebo and donepezil arms.